ORGS Orgenesis
- 0.527
- -0.016-2.95%
- 0.525
- -0.002-0.38%
Orgenesis News
Orgenesis Inc Files For Mixed Shelf Of Up To $100M- Sec Filing
Orgenesis Inc Files For Mixed Shelf Of Up To $100M- Sec Filing
Orgenesis Says Major Transformation Underway Commencing With Recent Acquisition; Says Recently Secured $2.3M Investment
Orgenesis Says Major Transformation Underway Commencing With Recent Acquisition; Says Recently Secured $2.3M Investment
Press Release: Orgenesis Provides Year End Business Update
Orgenesis Provides Year End Business Update Major transformation underway commencing with recent acquisition reasserting full ownership and control over Octomera Secured a $2.3 million investment f
12 Health Care Stocks Moving In Wednesday's After-Market Session
GainersRallybio (NASDAQ:RLYB) shares rose 31.9% to $2.15 during Wednesday's after-market session. The company's market cap stands at $81.2 million. Vera Therapeutics (NASDAQ:VERA) shares increased by
Germfree and Orgenesis Announce Asset Purchase and Strategic Partnership Intended to Revolutionize Cell and Gene Therapy Through Decentralized Production and Global Accessibility
ORMOND BEACH, Fla. and GERMANTOWN, Md., April 10, 2024 (GLOBE NEWSWIRE) -- Germfree, a leading innovator in modular cleanroom infrastructure and services, and Orgenesis Inc. (NASDAQ:ORGS), a global leader in
12 Health Care Stocks Moving In Thursday's After-Market Session
GainersOrgenesis (NASDAQ:ORGS) shares increased by 8.5% to $0.63 during Thursday's after-market session. The company's market cap stands at $21.4 million. AN2 Therapeutics (NASDAQ:ANTX) shares increas
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
GainersARCA biopharma (NASDAQ:ABIO) stock moved upwards by 124.6% to $3.84 during Wednesday's pre-market session. The market value of their outstanding shares is at $55.6 million. Kintara Therapeutics
Earnings Week Ahead: Walgreens Boots Alliance, Carnival, GameStop and More
Vered Caplan, CEO of Orgenesis, to Present at the Bioprocessing Summit Europe Conference
GERMANTOWN, Md., March 18, 2024 (GLOBE NEWSWIRE) -- Orgenesis Inc. (NASDAQ:ORGS) ("Orgenesis" or the "Company"), a global leader in decentralizing cell and gene therapies (CGTs), today announced that its CEO, Vered
Orgenesis Consortium Awarded €1.5M EUR Grant From the Walloon Government in Belgium for EXOFASTTRACK Project Dedicated to Accelerated Development of Multiple Therapeutic Exosomes
GERMANTOWN, Md., March 13, 2024 (GLOBE NEWSWIRE) -- Orgenesis Inc. (NASDAQ:ORGS) ("Orgenesis" or the "Company"), a global leader in decentralizing cell and gene therapies (CGTs), today announced that the Company has
Orgenesis Announces $2.3M Private Placement
Orgenesis Announces $2.3M Private Placement
Press Release: Orgenesis Consortium Awarded EUR2.0M EUR Grant From Walloon Government in Belgium for MAIDAM AI Project for Monitoring Decentralized ATMP Manufacturing
Orgenesis Consortium Awarded EUR2.0M EUR Grant from Walloon Government in Belgium for MAIDAM AI Project for Monitoring Decentralized ATMP Manufacturing GERMANTOWN, Md., Feb. 29, 2024 (GLOBE NEWSWIRE)
12 Health Care Stocks Moving In Monday's After-Market Session
GainersTrxade Health (NASDAQ:MEDS) stock rose 105.3% to $8.5 during Monday's after-market session. The company's market cap stands at $10.2 million. Iovance Biotherapeutics (NASDAQ:IOVA) shares moved
12 Health Care Stocks Moving In Monday's Pre-Market Session
GainersAutonomix Medical (NASDAQ:AMIX) stock rose 30.3% to $4.95 during Monday's pre-market session. The market value of their outstanding shares is at $93.0 million. As per the news, the Q3 earnings
12 Health Care Stocks Moving In Thursday's Intraday Session
GainersSientra (NASDAQ:SIEN) stock rose 193.5% to $0.53 during Thursday's regular session. The market value of their outstanding shares is at $6.3 million. Hepion Pharmaceuticals (NASDAQ:HEPA) stock i
Dakota Gold And 2 Other Stocks Under $3 Insiders Are Buying
The Dow Jones index closed higher by more than 150 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and tr
Orgenesis(ORGS.US) 10% Shareholder Buys US$216.61K in Common Stocks
$Orgenesis(ORGS.US)$ 10% Shareholder Safier Jacob purchased 375.24K shares of Common Stocks on Sep 7, 21, 28, Oct 5, 6, 10, 24, 25, 27, 31, Nov 1, 2, 8, 9, 10, 21, 24, Dec 1, 11, 12, 21, 2023 and Jan
Revenues Working Against Orgenesis Inc.'s (NASDAQ:ORGS) Share Price Following 36% Dive
To the annoyance of some shareholders, Orgenesis Inc. (NASDAQ:ORGS) shares are down a considerable 36% in the last month, which continues a horrid run for the company. The recent drop completes a d
EXCLUSIVE: Orgenesis Acquires Control of Octomera, Takes One Step Closer To Progressing Its Decentralized Immuno-Oncology Portfolio To Clinic
Orgenesis Inc (NASDAQ:ORGS) has entered into a definitive agreement with MM OS Holdings, an affiliate of Metalmark Capital Partners, to acquire its approximate 25% stake in Octomera.Octomera is Orgene
EXLCUSIVE: Orgenesis Tells Benzinga 'Metalmark Shall Receive a Royalty of 5% of the Net Revenue of Octomera's Cell Processing Services, for the Three Calendar Years 2025-2027'
EXLCUSIVE: Orgenesis Tells Benzinga 'Metalmark Shall Receive a Royalty of 5% of the Net Revenue of Octomera's Cell Processing Services, for the Three Calendar Years 2025-2027'
Analysis
Price Target
No Data
